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ABSTRACT
Policy makers in low-income and lower-middle-income countries (LMICs) are increasingly looking to develop ‘evidence-
based’ frameworks for identifying priority health interventions. This paper synthesises and appraises the literature on
methodological frameworks –which incorporate economic evaluation evidence – for the purpose of setting healthcare priorities
in LMICs. A systematic search of Embase, MEDLINE, Econlit and PubMed identiﬁed 3968 articles with a further 21 articles
identiﬁed through manual searching. A total of 36 papers were eligible for inclusion. These covered a wide range of health
interventions with only two studies including health systems strengthening interventions related to ﬁnancing, governance and
human resources. A little under half of the studies (39%) included multiple criteria for priority setting, most commonly equity,
feasibility and disease severity. Most studies (91%) speciﬁed a measure of ‘efﬁciency’ deﬁned as cost per disability-adjusted life
year averted. Ranking of health interventions using multi-criteria decision analysis and generalised cost-effectiveness were the
most common frameworks for identifying priority health interventions. Approximately a third of studies discussed the
affordability of priority interventions. Only one study identiﬁed priority areas for the release or redeployment of resources.
The paper concludes by highlighting the need for local capacity to conduct evaluations (including economic analysis) and
empowerment of local decision-makers to act on this evidence.
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1. INTRODUCTION
Policymakers are increasingly looking to develop ‘evidence-based’ priority-setting frameworks for the health sector
that incorporate value for money criteria. This is especially important in low-income and lower-middle-income
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countries (LMICs) where resources are highly constrained and public provision of a basic package of healthcare
services is often beyond reach. The budgeting process in many LMICs requires that government departments
prepare their plans and budgets based on prioritisation of interventions to support the achievement of the
Millennium Development Goals, Sustainable Development Goals and the pursuit of Universal Health Coverage
(Tangcharoensathien et al., 2013). From an economic perspective, priority setting can be seen as an ‘explicit’
process for choosing the optimal portfolio of programmes from a limited national healthcare budget (Hauck
et al., 2004). Priority setting can occur at the global, regional, and national or subnational level and involves both
the identiﬁcation and weighting of criteria and a framework for establishing priorities (Oxman et al., 2006). Put
simply, it is about who gets what at whose expense (Williams, 1988).
A range of frameworks has been used to set priorities on the basis of value for money. One approach
has been to compare the cost-effectiveness of different interventions using a quality-adjusted life year
(QALY) league table. This involves ranking interventions according to their ‘incremental cost per
QALY’ and then allocating funds starting at the top of the list and working down, in theory, stopping
once the prevailing budget has been exhausted (Mauskopf et al., 2003; Gerard and Mooney, 1993).
Alternatively, such decisions are made with reference to a threshold or ceiling, whereby all interventions
below should be funded and those above not (Marseille et al., 2015; Cleemput et al., 2011). For exam-
ple, generalised cost-effectiveness ratios, initiated by the World Health Organisation, compare the cost
and health beneﬁts of packages of different interventions against a situation in which those interventions
did not take place (Murray et al., 2000). Using a threshold based on multiples of gross domestic product
per capita, the results are then put in three categories: very cost-effective, cost-effective, and not cost-
effective (Hutubessy et al., 2002).
Another approach is program budgeting and marginal analysis (PBMA) (Mooney, 2002; Mitton and
Donaldson 2004). PBMA provides an information framework to allow a picture of where resources are
currently going (programme budgeting) and thereafter looking at whether a movement of resources from one
programme to another might increase total beneﬁts (marginal analysis). There are even broader frameworks that
take account of efﬁciency criteria, including option appraisal, multi-criteria decision analysis (MCDA) and mul-
tiple attribute utility analysis (Mooney et al., 2012). MCDA, in particular, is increasingly being used to evaluate
healthcare interventions and involves the systematic deﬁnition of criteria relevant to a decision, the performance
of options against these criteria and often the weighting of criteria to produce an overall value metric (Baltussen
et al., 2006; Marsh et al., 2014). According to Mooney et al. (2012), approaches like these represent ways of
allowing often-difﬁcult-to-measure attributes (such as patient reassurance) to be included and weighted
alongside efﬁciency criteria. Guidance is also available on how equity criteria can be considered in addition
to cost-effectiveness analysis for priority setting (Norheim et al., 2014; Cookson et al., 2009).
What is our deﬁnition of priority setting? What makes these examples of priority-setting frameworks and
sets them apart from all economic evaluation studies is that a funding decision is central to the analysis as
opposed to an intervention. These studies seek to identify priority areas for investment (or disinvestment) often
taking into account a range of organisational objectives including (but not limited to) efﬁciency. While eco-
nomic evaluation studies in health provide evidence based on the relative cost of achieving units of health gain,
priority-setting studies centre on the ultimate investment decision. In such decisions, there are potentially mul-
tiple inputs and inﬂuences, one of which is cost-effectiveness information. Several reviews of priority-setting
approaches that incorporate efﬁciency criteria are available for high-income countries (HICs; see, e.g. Mooney
et al., 2012; Robinson et al., 2012; Bate and Mitton, 2006; Noorani et al., 2007; Hauck et al., 2004). While less
is known about comparable frameworks used in LMICs, recent informal reviews point to a growing level of
interest in evidence-based priority setting by policy makers in these countries (see, e.g. Glassman et al.,
2013; Hipgrave et al., 2014). This review builds on the existing priority-setting literature by concentrating
on LMICs and, secondly, by adopting a transparent and explicit approach to the selection and assessment of
methodological frameworks (which incorporate economic evaluation evidence) for priority setting in health
care. A systematic review of wider issues such as acceptability and stakeholder engagement associated with
priority setting was outside the remit of this review.
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2. METHODS
The review focused on papers describing frameworks for setting healthcare priorities and included some assess-
ment of relative costs and consequences of healthcare interventions.
As the term ‘priority setting’may not be universally used, we adopted a comprehensive search strategy using
a series of broad but related terms and then carried out extensive manual reviews to ﬁlter out those papers that did
not meet our deﬁnition of priority setting (as set out in Section 1). The authors initially reviewed 20 papers that
they felt were relevant to the research question. The subject headings of these papers were reviewed in
MEDLINE and Embase in order to ascertain the pertinent subject headings and signiﬁcant text
words/keywords from the abstracts. Subsequently, a template search was developed in MEDLINE (Ovid) that
included three concepts: priority setting, cost, and low-income or lower-middle-income countries. Each concept
was composed of MeSH subject headings and keywords in order to develop a sensitive search strategy. The low-
income and lower-middle-income concept included country names based on the World Bank’s (2014) deﬁned
list. The MEDLINE search was translated into the appropriate terms in Embase (Ovid), PubMed and EconLit
(EBSCOhost). The search strategy (including a complete list of search terms) is shown in Web appendix. This
was supplemented by a search of relevant papers’ reference lists. All references were exported to RefWorks.
Papers were eligible for inclusion if they were published in the peer-reviewed literature between 2004 and
2014, were complete (e.g. conference abstracts were excluded) and were reported in the English language. All
paper types (with the exception of books) were included. Eligible papers also needed to report on at least one
‘low’-income or ‘lower-middle’-income country as deﬁned by the World Bank (World Bank, 2014).1 Studies
that referred to ‘developing countries’ were also included despite not specifying an individual country. Eligible
papers needed to report on priority-setting frameworks or approaches that considered a portfolio of interven-
tions for a particular disease, programme or entire health sector.
Two independent reviewers (V.W. and C.M.) screened the ﬁrst 83 articles against the inclusion criteria to
determine inter-rater reliability of the reviews. Any disagreement in article selection was discussed until consensus
was reached. Agreement was assessed using a simple kappa analysis (Cohen, 1960). Substantial agreement
(deﬁned as kappa exceeding 0.6) was desired for a decision to continue with a single reviewer (Landis and Koch,
1977). The calculated kappa score was 0.78, classifying the level of agreement as ‘almost perfect’ (Landis and
Koch, 1977). Screening for article selection was then completed by one reviewer (V.W.). A second reviewer
(C.M.) was consulted when clarity was needed. Both reviewers read the full text of the selected articles and
resolved disagreements by consensus. Reasons for inclusion and exclusion were recorded.
A data extraction form was designed and piloted for this study which included ﬁelds for the following
descriptive data: date and location of the study; type of paper (modelling, commentary, review, framework
development, etc.); country in which the study was undertaken; scale (global, regional, national or subnational);
type of health interventions; criteria used for priority setting; technique used to measure efﬁciency; name of
priority-setting process; and main data sources. The data were initially extracted by one reviewer (V.W.). A
second reviewer (C. M., L. C. or T. D.) independently extracted the same data for all papers, and any
disagreements were resolved. All variables included in the data extraction form are deﬁned in Table I.
Uniformly recognised criteria for appraising studies in this ﬁeld are not available. Guidelines developed
for PBMA by Peacock et al. (2010) were adapted for the appraisal of studies in this review. Five key
questions were asked of each study: (i) Was the perspective of the study determined? (ii) Was a sensitivity
analysis performed? (iii) Was affordability of the health interventions considered? (iv) Did the study consider
releasing or redeploying resources (as well as investment)? and (v) Was the study embedded in the local
policy and planning context with involvement by local decision-makers? Table IV summarizes the
reviewer responses to these appraisal questions for each of the included papers.
No ethical approval was required for this systematic review.
1These classiﬁcations are based on estimates of gross national income per capita for the previous year (World Bank, 2014).
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3. RESULTS
3.1. Study selection
The search in Embase, MEDLINE, Econlit and PubMed identiﬁed 3968 articles, and a further 21 articles were
identiﬁed through manual searching of reference lists. After the removal of duplicates, 3061 titles and abstracts
were screened against the inclusion criteria. Of these, 123 full articles were assessed for eligibility with 36 articles
meeting the inclusion criteria and kept for data abstraction (Figure 1). A complete list of the papers can be found in
Appendix 1. The main reasons for excluding studies was that despite mentioning priority setting, costs and
cost-effectiveness in the abstract or paper, they did not focus on the health sector or the funding of a package of
healthcare interventions.
3.2. Study characteristics
Table II shows that of the 36 eligible papers, 15 involved studies of priority setting at the national level (11 from
African countries), 14 at the regional level and 9 at the global level.2 The majority of studies (19) took a modelling
approach.
Table III shows that studies covered a broad range of health interventions with only two studies including health
systems strengthening interventions related to ﬁnancing, governance, information and human resources for health
(#4 and #12). A little under half of all studies (39%) included at least one other criterion apart from efﬁciency for
priority setting, most commonly ‘equity’ and ‘feasibility’. Most studies (91%) speciﬁed a measure of ‘efﬁciency’,
Table I. Description of variables/questions for data extraction
Variable/question Deﬁnition
Overview of peer-reviewed papers
Author/year Authors of the article and year of publication.
Country Location of the priority-setting exercise.
Paper type Description of the study by authors – review, economic modelling, exploratory/
pilot study, strategic planning document and framework development.
Scale Global, regional and national/sub-national.
Methods and data sources
Interventions Type of health sector interventions to be prioritised.
Criteria Stated criteria upon which priorities were set.
Efﬁciency measure Cost-effectiveness (including cost-utility) or cost–beneﬁt analysis. Includes ratio
used (e.g. cost per DALY averted or cost per QALY gained).
Priority-setting approach Framework into which efﬁciency (and other) criteria feed (e.g. ranking of
interventions based on multi-criteria decision analysis or generalised cost-
effectiveness approach, programme budgeting and marginal analysis, etc.)
Data source Literature (peer-reviewed literature and open-access databases), expert/
stakeholder opinion, primary data collection.
Appraisal
Was the perspective of the economic analysis
speciﬁed?
Perspective or viewpoint of the economic analysis. Includes society or provider.
(Yes/No/Not applicable)
Was allowance made for uncertainty in the
estimates of costs and consequences?
Identiﬁcation and testing of uncertain parameters associated with costs and
consequences. (Yes/No/Not applicable/Some)
Was affordability of priority interventions
discussed/measured?
Recognition of an explicit budget constraint. (Yes/No/Not applicable/Some)
Did the exercise investigate disinvestment as
well as investment in health interventions?
Decommissioning, disinvesting or redeploying resources from currently
funded interventions. (Yes/No/Not applicable)
Was the study embedded in the local policy and
planning context?
Broad indication of likely impact and sustainability of the priority-setting
framework on decision-making. (Yes/No/Not applicable)
2Some studies looked at more than one level
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commonly deﬁned as cost per disability-adjusted life year (DALY) averted (72%). Only one study calculated cost per
QALY gained (#8), and one study estimated costs and beneﬁts in monetary terms to derive a beneﬁt–cost ratio (#20).
In reviews such as this where the topic and questions being asked are broad, heterogeneity is inevitable both
in terms of methods and outcomes. Priorities were derived through a range of approaches including MCDA,
generalised cost-effectiveness approach (GCEA), balance sheet method and an approach akin to PBMA
(Mooney, 2002). GCEA and MCDA were the most common approaches used in 40% and 18% of studies,
respectively. All of the GCEA studies relied on data from the WHO Choosing Interventions that are Cost-
effective Project. Most studies relied on secondary data for priority setting and noted several gaps in the evidence
base especially in relation to effectiveness data, which often resulted in country-level studies relying on regional
data or expert opinion. The priority interventions identiﬁed by the different studies were also diverse,
representing mixes of curative and preventive actions and of population and individually focused interventions.
3.3. Appraisal
Around half (45%) of the studies took a societal perspective for the economic analysis, and 27% did not spec-
ify any perspective (Table IV). It was also revealed that 58% of studies undertook a sensitivity analysis
(which was most often a one-way univariate analysis), and 51% assessed the affordability of priority interven-
tions. This was most often carried out through a threshold analysis designed to reﬂect the opportunity cost of
investment or through a budget impact analysis whereby an intervention is said to have a large budget impact
when it costs more than an arbitrarily deﬁned proportion of annual public health expenditure (i.e. more than
10%). Only one study investigated the issue of disinvestment and identiﬁed priority areas for reduced
healthcare spending (#4). Only three studies were embedded in local appraisal and budgeting processes
involving policy makers and ministerial ofﬁcials responsible for healthcare investments (#4, #11 and #21).
It should be noted that the appraisal question concerning local stakeholder involvement was only applicable
to 12 studies because the remaining ones were either systematic reviews or designed to test a tool or focussed
on priority setting at the global or regional level. Also, any studies for which the appraisal category is
recorded as ‘not applicable’ were excluded from the total number of studies included in the denominator.
Figure 1. Selection of studies ﬂow chart. *Authors contacted to conﬁrm that a full paper was not available. **Priority setting papers that do
not focus directly on health. ***Information captured in other papers. PS, priority setting; CE, cost effectiveness
Correction has been added on 16 February 2016, following initial online publication 25 January 2016. Sentence “MCDA and GCEA were
the most common approaches used in 42% and 18% of studies, respectively.” was changed to “GCEA and MCDA were the most common
approaches used in 40% and 18% of studies, respectively.”
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Table IV. Appraisal of priority-setting frameworks
Article Author(s)
Was the perspective
of the economic
analysis speciﬁed?
Was allowance
made for
uncertainty in
the estimates of
costs and
consequences?
Was affordability
assessed?
Did the exercise
investigate
disinvestment as
well as
investment?
Was the
study
embedded
in the local
policy and
planning
context?
#1 Baltussen
et al, 2007
Y (societala) N N N N
#2 Hansen &
Chapman, 2008
Y (provider) Y N N N
#3 Kapiriri &
Norheim, 2004b
N N/A N/A N/A N
#4 Kase, 2006 Y (provider) N Y – budget thresholdc Y Y
#5 Baltussen, 2006 Y (provider) N Y – budget impact
analysisd
N N
#6 Baltussen et al.,
2006
Y (societal) N Y – budget impact
analysise
N N
#7 Chisholm et al, 2008 N Y N N N/A
#8 Diaby & Lachane,
2011
Y (provider) Y Y – budget impact
analysisf
N N
#9 Evans, Lim
et al, 2005
Y (provider) Y Y – budget thresholdg N N/A
#10 Ginsberg et al,
2012
Y (societal)h Y N N N/A
#11 Jehu-Appiah
et al, 2008
Y (societal) N N N Y
#12 Laxminarayan
et al., 2006
Y (provider) N N N N/A
#13 Makundi et al.,
2007
N N N N N
#14 Venhorst et al,
2014
N N Y – measure not speciﬁed N N/A
#15 Marsh et al., 2014 Somei Somej Some – budget impact
analysisk
N N/A
#16 Chao et al, 2014 Some Somel N N N/A
#17 Diaby et al., 2011 Y (provider) N Y – budget impact
analysism
N N/A
#18 Simons et al, 2011 Y (providern) Y N N N/A
#19 Canning, 2006 N N N N N/A
#20 Whittington et al.,
2012
N Y N N N/A
#21 Madi et al., 2007o N/A N/A N/A N/A Y
#22 Adam et al., 2005 Y (societalh) N Y – budget thresholdg Y N/A
#23 Baltussen et al,
2005
Y (societalh) Y Y – budget thresholdg N N/A
#24 Baltussen, 2012 Y (societalh,p) Y N N N/A
#25 Chisholm, Baltussen
et al, 2012
Y (societalh) N N N N/A
#26 Chisholm, Naci
et al, 2012
Y (societalh) Y N N N/A
#27 Chisholm, Saxena
et al, 2012
Y (societalh) Y Y – budget thresholdq N N/A
#28 Darmstadt et al,
2005
Y (societalh) Y Y – budget thresholdq N N/A
#29 Edejer et al, 2005 Y (societalh) Y Y – budget thresholdg N N/A
#30 Morel et al, 2005 Y (provider) Y Y – budget thresholdg N N/A
#31 Ortegon et al, 2012 Y (societalh) Y Y – budget thresholdr N N/A
#32 Stanciole et al,
2012
Y (societalh) Y Y – budget thresholdq N N/A
(Continues)
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4. DISCUSSION
The need for priority setting and trading-off between potentially beneﬁcial and life-saving investments options
is a universal problem. It is especially important in highly resource-constrained settings where the most basic
health services are sometimes unaffordable and where there is a heavy reliance on international donor support.
As such, policy makers in LMICs and donors are increasingly looking to develop ‘evidence-based’ approaches
for setting investment priorities in the health sector. This review of the peer-reviewed literature provides a
comprehensive overview of the different frameworks designed to take account of the problem of resource
scarcity and incorporate the assessment of relative costs and effects of interventions in LMICs.
This review shows that there is widespread acknowledgement that decisions on the allocation of scarce
healthcare resources are shaped by a range of criteria and that economic evaluation information must be con-
sidered alongside other health system goals. Approximately half of the studies in this review included multiple
criteria for priority setting. Some studies also reported different priorities based on efﬁciency versus
Table IV. (Continued)
Article Author(s)
Was the perspective
of the economic
analysis speciﬁed?
Was allowance
made for
uncertainty in
the estimates of
costs and
consequences?
Was affordability
assessed?
Did the exercise
investigate
disinvestment as
well as
investment?
Was the
study
embedded
in the local
policy and
planning
context?
#33 Hogan et al, 2005 Y (societal) Y Y – budget thresholdg N N/A
#34 Cecchini et al 2010 N Y N N N
#35 Chisholm, Doran
et al, 2006
N Somes N N N/A
#36 Gureje et al, 2007 N N Y – budget thresholdt N N
Y, Yes; N, No; N/A, not applicable; Some.
aCost-effectiveness data are derived from the WHO CHOICE project, which is reported to take a societal perspective (Evans et al., 2005).
bThis study only sought to derive criteria for priority setting.
cThreshold not speciﬁed.
dBudget impact was one of the criteria for priority setting. Budget impact was not measured.
eIntervention was deﬁned as having a large budget impact when it costs more than (an arbitrarily deﬁned) $US15 million (i.e. >10% of
annual public health expenditure).
fBudget Impact Analysis (BIA) suggests that the new priority list of reimbursable drugs deemed affordable if the real economic impact of drugs per
member is less than $US66.
gInterventions to be highly cost-effective if they cost less than the gross domestic product per capita to avert each disability adjusted life
years (DALY) and cost-effective if each DALY could be averted at a cost of between one and three times the gross domestic product
per capita. Other interventions are not cost-effective. According to the authors, this incorporates an element of affordability as regions
and countries with lower national income will have lower cut-off points.
hThese classiﬁcations are based on estimates of gross national income (GNI) per capita for the previous year (World Bank, 2014).
iThis review includes a checklist that assesses whether a ‘well-deﬁned question was posed in answerable form’ (Drummond et al., 2005).
This was taken to include a description of study viewpoint.
jAccording to the authors, approximately half of the studies in the review conducted a sensitivity analysis.
kOf the 40 studies, three included budget impact as a criterion for priority setting. Budget impact was not measured.
lAccording to the authors, the majority of studies included in the review conducted a sensitivity analysis.
mBudget impact analysis was recommended as one of the drug selection criterion. Budget impact not measured as part of the proposed framework.
nObtained from companion costing paper by Wolfson et al. (2008).
oThis study only sought to derive criteria for priority setting.
pAuthors note that they did not include time costs of people seeking and undergoing care or changes in productivity losses as a result of the interventions.
qIntervention packages deemed ‘very cost effective’ if below average per-person GDP, or Intl$1391. Implies an element of affordability as
countries with lower national income will have lower cut-off points.
rUses average per capita income (which in both sub-regions is close to $Int2000) as a threshold for considering an intervention to be highly
cost-effective. Implies an element of affordability as regions and countries with lower national income will have lower cut-off points.
sAccording to the authors, the majority of studies performed a sensitivity analysis.
tUses average per capita income in Nigeria (which is $US320) as a threshold for considering an intervention to be highly cost-effective.
According to the authors, the total ﬁnancial outlay of government for the most highly cost-effective package of mental health interventions
is estimated to be relatively small (less than $US1 per capita).
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non-efﬁciency criteria, thereby highlighting the importance of specifying the relevant criteria at the outset of
any priority-setting exercise (Diaby et al., 2011; Johansson and Norheim, 2011). Overlap between different
criteria was recognised as an additional methodological issue requiring greater attention by researchers. In
the MCDA literature, for example, studies included related criteria such as ‘cost of treatment’, ‘effectiveness
of treatment’ and ‘cost-effectiveness of treatment’ (see, e.g. Marsh et al., 2014; Diaby et al., 2011).
In LMICs, the most common framework in the peer-reviewed literature for explicit prioritising of healthcare
interventions is the league table approach. These tables are typically based on MCDA where simultaneous
criteria are used or on GCEA where only efﬁciency criterion is used. Cost per DALY averted is the dominant
measure of cost-effectiveness, and it is often justiﬁed on the grounds that almost 90% of the global burden of
disease is accounted for by LMICs (Murray and Lopez, 1997; Zarate, 2007). PBMA, which creates a manage-
ment process into which results from standard economic evaluations and other evidence can be incorporated
(Ruta et al., 2005), has been widely used in HICs including Australia, Canada, New Zealand and the UK
(Mitton et al., 2014) but has not established a footing in LMICs. In addition to the widespread problem of a
lack of credible information, the legitimacy and capacity of institutions management processes are often weak.
Criteria such as ‘feasibility’ and ‘sustainability’ frequently feature amongst priority-setting criteria in LMICs,
which again may reﬂect the constrained capacity of local priority-setting institutions.
This review also revealed a distinction between frameworks developed for use at the global and regional level
versus those designed to set priorities at the country level. There have been an increasing number of sector-wide
frameworks such as The WHO Choosing Interventions that are Cost-Effective Project and the Disease Control
Priorities Project that have been led largely by the international community seeking to identify the most cost-
effective interventions for achieving targets such as the Millennium Development Goals and Universal Health
Coverage. These two projects represented approximately half of all studies included in this review. It has been
argued that while these analyses provide an indication of value for money, they do so at the expense of diversity
or speciﬁcity of individual country contexts (Makundi et al., 2007). In contrast, country-level priorities are often
based on more consultative processes that require signiﬁcant investment in building relationships and engaging
and empowering stakeholders (Madi et al., 2007). To date, there has been little recognition in the priority-setting
literature of the diversity of stakeholders involved in both the funding and implementation of healthcare inter-
ventions in LMICs. Most country-level priority-setting analyses make the implicit assumption that the national
government has over-arching responsibility for priority setting, but in reality, substantial healthcare funds are
already earmarked for speciﬁc interventions or disease areas based on the priorities of international or transna-
tional non-governmental organisations. Consequently, priority-setting frameworks often fail to reﬂect the mul-
tifaceted nature of priority setting in many LMICs. Global institutions responsible for setting priorities should be
lobbied to use and disclose their frameworks especially those receiving public money and be made accountable
for how their activities might distort national-level and local-level priority setting. Recent initiatives such as the
Asia-Paciﬁc Regional Capacity Building for Health Technology Assessment, a collaboration between the Inter-
national branch of the National Institute of Clinical Excellence (UK) and countries in the region, are designed to
provide technical support to governments in LMICs to help build up their priority-setting capacity and to support
multi-stakeholder engagement (Teerawattananon et al., 2014; NICE International, 2014).
A lack of cost-effectiveness evidence for many key health interventions in LMICs is another limitation to
explicit priority setting at both the global and country level. The results of this review show that most studies
base their analyses on extremely limited efﬁcacy and effectiveness data or on expert opinion. Moreover, extrap-
olation of best available international evidence – from higher to lower income resource settings is often
required but can be problematic due to clear differences in health systems and epidemiology (Adam et al.,
2005; Chisholm and Saxena, 2012). However, priority-setting approaches examined in this review tended to
lack any account of uncertainty, utilising single-point estimates for effectiveness and cost-effectiveness.
Given these information gaps, priority-setting studies in LMICs utilise economic evaluation data frommany different
settings. In doing so, methodological inconsistencies are inevitable. Interventions that are deemed to be cost-effective in
one setting may not be in another especially where coverage rates, disease incidence, relative prices and costs are differ-
ent. These factors affect the applicability and reliability of evidence underpinning priority-setting approaches. However,
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extrapolations are a necessary part of these exercises, and as such, evaluators working with decision-makers need to
adapt to the use of imperfect, ‘broad brushed’ data in a pragmatic way to inform a decision at hand (Mooney, 1994).
A bigger problem observed in several studies was the practice of excluding potential interventions from consideration
due to a lack of data (Adam et al., 2005). Because ultimately priority setting is about assessing as many competing op-
tions as feasible, such omissions undermine the validity of these exercises by introducing clear bias into their recommen-
dations. Future initiatives need to be based more strongly on pragmatic responses to imperfect data.
This review also highlighted that many priority-setting exercises are based on unrealistic assumptions about the
overall functioning of health systems in LMICs. The expected costs and effects of priority health interventions depend
on accompanying investments in health systems to support appropriate levels of human resources, timely referral sys-
tems, efﬁcient and equitable ﬁnancing systems and adequate institutional infrastructure (Laxminarayan et al., 2006).
A common weakness of many priority-setting initiatives is that investments in such infrastructure are not formally
deliberated upon and included amongst the options being considered nor are the potential unintended consequences
for health systems associated with shifting resources, such as staff from one programme to another. Priority-setting
exercises should not assume, for example, that a skilled workforce is available to deliver priority health interventions
in LMICs nor should it assume that shifting health workers from one programme to another is a costless exercise.
Another important message emerging from this review is the limited attention paid to identifying and
prioritising options for redeployment of resources. This is despite mounting evidence from around the world
demonstrating missed opportunities to improve health through reallocation of public monies towards more
cost-effective interventions (Glassman et al., 2013). While most studies in this review implied that highly
cost-effective interventions should be prioritised over less cost-effective ones, only one study provided a ‘real
life’ example of where resources were targeted for release (Kase, 2006). This is not a problem conﬁned to LMICs
and has been documented in many HICs (Jan, 2003; Elshaug et al., 2007; Mortimer, 2010). It has been argued
that problems with translating ‘wish lists’ of priority health interventions into action is typically a consequence
of a failure to release resources from elsewhere in the health budget (Mortimer, 2010). It has been recommended
that greater attention needs to be paid to creating stronger incentives for change by, for example, linking invest-
ment proposals to disinvestment proposals with relatively similar input requirements (Mortimer, 2010). Exam-
ples of good practice for resource release or redeployment do exist from HICs through the application of PBMA
in which MCDA has been employed as a tool for assessing relative value of services (Mitton et al., 2014);
however, again, translating this experience to LMICs has received limited attention to date.
The vast majority of economic evidence used in priority setting comes from cost-effectiveness analyses where
the measure used is typically cost per DALY averted. Only one priority-setting exercise relied on evidence from a
cost–beneﬁt analysis (Whittington et al., 2012). The overall focus on health outcomes often means that broader
welfare consequences such as improved production or increased days at school are not taken into account despite
being important for many interventions in LMICs (Evans et al., 2005). For example, it has been reported that
antiretroviral treatment for HIV and AIDs can help keep health workers and teachers in their posts and prevent a
possible breakdown in society (Pufall et al., 2014). Such limitations highlight a wider challenge in adapting top-
down approaches to priority setting to the preferences and values of local constituencies. The use of measures such
as cost per QALY in some LMICs has been justiﬁed on the grounds of local preferences being more important than
expert DALY weights (Chalkidou, Communication).
The ﬁndings of this review must be seen in the light of some limitations. First, we acknowledge that some priority-
setting initiatives are documented in the grey literature. We chose to conﬁne our search to the peer review literature
given the focus of this review is largely on methodological issues and that these publications are expected to have
undergone some basic quality control. Our search was also restricted to papers in the English language published in
the past 10 years. Thirdly, it was beyond the scope of this paper to comprehensively assess ‘impact’, deﬁned as the
degree to which priority-setting results fed into an appraisal process that was led or convened by budget holders.
Our appraisal, which askedwhether a studywas embedded in local budgeting processes, revealed that very few studies
met this criterion.While this provides some insight into the likely impact and sustainability of a priority-setting frame-
work, this is not a deﬁnitive measure of impact on actual resource allocation decision-making. Currently, much of the
evidence needed to assess policy impact is not routinely published, particularly in instances of failure in
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implementation. The task of attribution is further complicated by the delay that often occurs between the presentation
of evidence and of action, the multiple and complex inﬂuences that tend to bear on resource allocation decisions and
because the role of priority-setting evidence is not necessarily explicitly acknowledged when decisions are ultimately
made. As a result, the existing literature (peer reviewed or otherwise) is unlikely to be representative of what is really
happening on the ground in LMICs. Policy makers should be encouraged to document and share their experiences
with priority setting. Initiatives such as the Capacity Building Programme on Universal Health Coverage Academy
in Thailand (www.ihpp.thaigov.net/capuhc), coordinated by the International Health Policy Programme and funded
by Rockefeller, is likely to prove to be a much better source of priority-setting approaches than the western literature
alone.
Table V provides a summary of the different challenges discussed earlier and includes recommendations
about what might be done to encourage a more transparent and implementable way of using economic infor-
mation for priority setting in LMICs.
In conclusion, governments and donors are under mounting pressure to demonstrate greater accountability for
how limited health resources are used to meet health system goals in recipient countries. Increasing efforts are
therefore being made in LMICs to adopt a more explicit approach to priority setting whereby resources are
allocated with the intention of maximising value for money as well as other societal objectives. This review points
to a number of factors currently constraining the adoption of such an approach in LMICs. Barriers associated
with poor data and limited technical capacity are not new and have been noted in other reviews of priority setting
(see, e.g. Glassman et al., 2013). Incorporation of the wider practical constraints arising from the political and
institutional context, building local capacity, identifying areas for disinvestment and identifying unintended
consequences for the wider health system remain some of the least-developed aspects of the priority-setting
literature and have particular relevance in resource-constrained settings. Consideration of these constraints will help
strengthen priority-setting frameworks and encourage evidence-based decisions on healthcare spending in LMICs.
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